Vinay Prasad's acting replacement, remembering genomics pioneer J. Craig Venter, and more biotech news from The Readout ...

The FDA proposed excluding the active ingredients in popular obesity and diabetes drugs from a list of substances that can be ...

WASHINGTON — The Trump administration has dropped its nomination of Casey Means to be the next surgeon general, opting ...

Most of the infant formula in the U.S. is safe, but experts and health officials say regulators can take steps to make the ...

Efforts to make customized medicines at scale have hit commercial and regulatory roadblocks. Julia Vintarello is trying again ...

Psychedelics’ potential as a form of treatment is virtually unmatched. But their promise faces both scientific uncertainty ...

America is worried about fertility rates — again. Coverage of the country’s declining birth rate reflects widespread unease: ...

J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized ...

A new tool, OBSCORE, is meant to better define who's at risk for obesity complications, going beyond BMI to include family ...

The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of ...

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...

Elevance Health is blocking the deposition of Peter Haytaian, an outgoing executive who previously oversaw the health insurer ...